Back to Search Start Over

Should we really include systemic sclerosis specific antibodies in the classification criteria of Sjogren’s disease?

Authors :
François, Zimmermann
François, Robin
Simon, Cadiou
Nicolas, Belhomme
Patrick, Jégo
Guillaume, Coiffier
Alain, Lescoat
CHU Pontchaillou [Rennes]
Nutrition, Métabolismes et Cancer (NuMeCan)
Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)
Institut de recherche en santé, environnement et travail (Irset)
Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )
Source :
Seminars in Arthritis and Rheumatism, Seminars in Arthritis and Rheumatism, 2023, 58, pp.152158. ⟨10.1016/j.semarthrit.2022.152158⟩
Publication Year :
2023
Publisher :
HAL CCSD, 2023.

Abstract

International audience; We have read with great interest the results from Marketos et al. regarding the positivity of specific systemic sclerosis auto-antibodies in patients with sicca symptoms. Based on complementary data from the literature, we rather believe scleroderma-associated antibodies should be considered either as a yellow flag for an association between scleroderma and Sjogren, or a potential undiagnosed scleroderma, rather than an isolated Sjogren’s disease.

Details

Language :
English
ISSN :
00490172
Database :
OpenAIRE
Journal :
Seminars in Arthritis and Rheumatism, Seminars in Arthritis and Rheumatism, 2023, 58, pp.152158. ⟨10.1016/j.semarthrit.2022.152158⟩
Accession number :
edsair.doi.dedup.....ccd9a96ec4e1bf460bfc6fa5a670afb0
Full Text :
https://doi.org/10.1016/j.semarthrit.2022.152158⟩